CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00008
Full Text
Open PDFAbstract
Available in full text
Date
February 11, 2020
Authors
Publisher
Frontiers Media SA